Department of General Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, 280 Mohe Road, Shanghai, 201999, China.
Surg Endosc. 2020 Sep;34(9):4030-4040. doi: 10.1007/s00464-019-07192-0. Epub 2019 Oct 16.
In this study, we aimed to identify independent predictive factors for lymph node metastasis (LNM) in T1 colon cancer.
Data of 8056 eligible patients were retrospectively collected from the Surveillance, Epidemiology, and End Results (SEER) database during 2004-2012. We performed logistic regression analysis to identify predictive factors for LNM. Both unadjusted and adjusted Cox regression analyses were used to determine the association between LNM and patient survival. Finally, we used competing risks analysis and the cumulative incidence function (CIF) to further confirm the prognostic role of LNM in cancer-specific survival (CSS).
The overall risk of LNM in patients with T1 colon cancer was 12.0% (N = 967). Adjusted logistic regression models revealed that mucinous carcinoma [odds ratio (OR) = 2.26, P < 0.001], moderately differentiated (OR 1.74, P < 0.001), poorly differentiated (OR 5.16, P < 0.001), and undifferentiated carcinoma (OR 3.01, P = 0.003); older age (OR 0.66, P < 0.001 for age 65-79 years, OR 0.44, P < 0.001 for age over 80 years); and carcinoma located in the ascending colon (OR 0.77, P = 0.018) and sigmoid colon (OR 1.24, P = 0.014) were independent predictive factors for LNM. Adjusted Cox regression analysis showed that positive lymph node involvement was significantly associated with CSS [hazard ratio (HR) = 3.02, P < 0.001], which was further robustly confirmed using a competing risks model and the CIF.
This population-based study showed that mucinous carcinoma, tumor grade, age, and primary tumor location were independent predictive factors for LNM in T1 colon cancer. The risk of LNM should be carefully evaluated in patients with T1 colon cancer, before clinical management.
本研究旨在确定 T1 期结肠癌淋巴结转移(LNM)的独立预测因素。
回顾性收集 2004 年至 2012 年期间来自监测、流行病学和最终结果(SEER)数据库的 8056 名合格患者的数据。我们进行逻辑回归分析以确定 LNM 的预测因素。使用未调整和调整后的 Cox 回归分析来确定 LNM 与患者生存之间的关联。最后,我们使用竞争风险分析和累积发生率函数(CIF)进一步证实 LNM 在癌症特异性生存(CSS)中的预后作用。
T1 期结肠癌患者的总体 LNM 风险为 12.0%(N=967)。调整后的逻辑回归模型显示,黏液腺癌(优势比[OR] = 2.26,P<0.001)、中分化(OR 1.74,P<0.001)、低分化(OR 5.16,P<0.001)和未分化癌(OR 3.01,P=0.003);年龄较大(年龄 65-79 岁的 OR 0.66,P<0.001,年龄>80 岁的 OR 0.44,P<0.001);以及升结肠(OR 0.77,P=0.018)和乙状结肠(OR 1.24,P=0.014)部位的癌与 LNM 独立相关。调整后的 Cox 回归分析显示,阳性淋巴结受累与 CSS 显著相关(风险比[HR] = 3.02,P<0.001),这在使用竞争风险模型和 CIF 时得到了进一步的稳健证实。
这项基于人群的研究表明,黏液腺癌、肿瘤分级、年龄和原发肿瘤部位是 T1 期结肠癌 LNM 的独立预测因素。在进行临床管理之前,应仔细评估 T1 期结肠癌患者的 LNM 风险。